Earnings Release & Supplemental Report

10-Q Filing
 

Discussion + Reconciliation of Non-GAAP Financial Measures

• EPS, FFO and FFO as adjusted per share, were ($0.02), $0.33 and $0.48, respectively
• Achieved year-over-year three-month SPP Cash NOI growth of 3.2%, including 5.3% in the SHOP portfolio
• Entered into transactions which provide a path to reduce Brookdale concentration to approximately 15.7% 
• Reentering the Boston life science market with $228 million acquisition of the Hayden Research Campus, bringing our year-to-date announced acquisitions and developments to $447 million 
• Announced launch of sales process for remaining UK holdings
• As previously announced, repurchased $500 million of our 5.375% senior notes due 2021
• Promoted Tom Klaritch to Chief Operating Officer and appointed Shawn Johnston as Chief Accounting Officer  
• Increased 2017 FFO as adjusted guidance range and reaffirmed aggregate 2017 SPP Cash NOI growth guidance